As we move into the next generation of life sciences technology, we identify data integration at the core. Artificial Intelligence in life sciences is impacting the way innovative health technologies and pharmaceuticals are discovered, distributed, manufactured, and consumed, enabling greater personalization across the industry. The power of AI lies in the vast mountains of data generated through R&D. As companies begin their R&D cycle, it is essential to reassess what data is considered valuable. VALUENEX presents a perspective of the next generation in life sciences innovation, analyzing that data that is often overlooked.

Presenter: Jiyoung Choi, COO, VALUENEX, Inc

July 18, 2019